The role of adjuvant chemotherapy in patients with locally advanced (pT3, pT4a) and/or lymph node-positive bladder cancer

---

Copy For Citation

Resorlu B., Turkolmez K., Ergun G., BALTACI S., Gogus C., Beduk Y.

INTERNATIONAL UROLOGY AND NEPHROLOGY, vol.42, no.4, pp.959-964, 2010 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 42 Issue: 4
• Publication Date: 2010
• Doi Number: 10.1007/s11255-010-9736-5
• Journal Name: INTERNATIONAL UROLOGY AND NEPHROLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.959-964
• Hacettepe University Affiliated: Yes

Abstract

To report the long-term follow up of patients with locally advanced bladder cancer treated with either adjuvant chemotherapy with gemcitabine/cisplatin (GC) or methotrexate, vinblastine, epirubicin, and cisplatin (MVEC) or no additional treatment after radical cystectomy, to examine various survival endpoints and factors associated with long-term survival.